Next Post

PharmEnable announces multi-target collaboration with Denali Therapeutics in neurodegenerative disease

PharmEnable, an AI drug-discovery company mapping unexplored chemical space to deliver innovative medicines, has announced a collaboration with Denali Therapeutics, a biopharmaceutical company developing a broad portfolio of product candidates engineered to cross the blood-brain barrier (BBB) for neurodegenerative diseases. In this collaboration, PharmEnable will leverage its proprietary AI drug […]